Bayer looks to new Eylea use in Japan; Hep C cases drop 16%; Stada says Ukraine business steady amid conflict;

@FiercePharma: As in...right now. The top 10 pharma companies by 2013 revenue report is live on the FP site. Report | Follow @FiercePharma

@TracyStaton: This year's version of FiercePharma's most popular special report: The top 10 pharma companies by 2013 revenue. More | Follow @TracyStaton

@EricPFierce: WSJ says Pfizer angling for OTC Lipitor. That will get generic drugmakers' notice. Story | Follow @EricPFierce

@CarlyHFierce: New report, now live: The top 10 pharma companies by 2013 revenue. Report | Follow @CarlyHFierce

> Bayer submitted its vision drug, VEGF Trap-Eye, for approval in patients with diabetic macular edema in Japan; it's sold elsewhere as Eylea. Release

> Germany's Stada says conflict in the Ukraine, its second-biggest market, hasn't affected its business in that country. Report

> Hepatitis C cases dropped 16% to 2.7 million over a decade, the Centers for Disease Control and Prevention, at a time when new treatments are edging onto the market. Report

> Many painkiller addicts visit multiple doctors to get their pills, suggesting physicians need to be more vigilant when recommending their use. Report

> Forest Laboratories ($FRX) said it submitted its application for FDA approval of a combination Alzheimer's disease pill comprising its Namenda drug (memantine) and donezepil, sold by Pfizer ($PFE) under the brand name Aricept. Release

Medical Device News

@FierceMedDev: Mindray, a giant Chinese medical device company, has just expanded an already impressive share repurchase program. More | Follow @FierceMedDev

@MarkHFierce: Google Glass is showing some promise as a medical diagnostic tool. Cool stuff, with pictures. Story | Follow @MarkHFierce

@MichaelGFierce: New manufacturing technique offers tailored delivery nanoparticles made of iron, silver and silicon. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Researchers created custom-fitting heart sacs that could help with treatment. Article | Follow @EmilyWFierce

> Invuity brings a new $36M in growth equity to the surgical tools market. News

> Germany's Biotronik wins a CE mark for a super-tiny, MRI-safe CRT lead. Story

> Oxford Immunotec reports narrowed loss, Asia growth in first earnings post-IPO. Report

Biotech News

@FierceBiotech: Theravance bets it can innovate without GlaxoSmithKline as spinoff nears. Story | Follow @FierceBiotech

@JohnCFierce: The coming Zohydro addiction issue is a natural mainstream media piece--sets the FDA up for a big black eye with more to come. Story via CBS | Follow @JohnCFierce

@DamianFierce: On his farewell tour, Roche Chairman Franz Humer says Roche is poised for some dealmaking. News | Follow @DamianFierce

@EmilyMFierce: BioCryst compound prevents Marburg virus in monkeys. Article | Follow @EmilyMFierce

> Oxygen Bio shares soar after FDA lifts hold on brain injury drug. More

> Biotech parties on with billions more raised for R&D work. Story

Biotech Research News

> HIV immune discovery could lay the groundwork for a vaccine. Story

> Experimental supplement extends lifespan, stops metabolic disease in mice. Article

> BioCryst compound prevents Marburg virus in monkeys. News

> New anti-inflammatory molecule could provide a model for new drug design. Article

> Brain cell communication plays role in regulating Alzheimer's protein. Story

> NIH makes new database on age-related diseases available to researchers. Brief

Pharma Manufacturing News

> Regeneron preparing for a plant expansion and a fill-finish facility in Ireland. Story

> Jubilant says the FDA has cleared its Canada plant. News

> Fresenius to build new plant in Australia. Story

> Lilly invests in its Brazilian packaging plant. Article

> Drug purchasing group wants drugmakers to work with GPOs on shortages. Story

> Pharma packaging market is forecast to hit $90 billion in 2017. Brief

And Finally... Scientists have been testing LSD to ease anxiety in the terminally ill. Report

Suggested Articles

Merck’s Keytruda went up against chemo in a head-to-head colorectal cancer battle—and won.

While the FDA gave an emergency green light to chloroquine's use against coronavirus, European regulators are restricting the drug to clinical trials.

Biocon has finally satisfied the FDA that its insulin production plant in Malaysia is ready for prime time.